Related Experiment Video
Updated: Sep 9, 2025

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Lamb Model of RSV Infection
Sarhad Alnajjar1,2, Jack Gallup3, Mark Ackermann4
1Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK. sarhad@lambcure.com.
Abstract:
Respiratory syncytial virus (RSV) is one of the leading causes of lower respiratory tract infections in infants and older adults. There are several animal models to study RSV infection and test the efficacy of antiviral compounds and vaccines. The lamb model has some advantageous features that contribute to it being one of the best animal models of RSV due to the similarity in size, biology, immune responses, and cellular/structural composition of the respiratory system to infants, the susceptibility to human RSV, and the possibility to investigate multiple approaches and experimental designs. Thus, the lamb model is considered and used as a preclinical model to evaluate the effectiveness and characterize the dosing and mechanisms of newly developed antiviral compounds before they move to human clinical trials. In this chapter, the detailed protocol for the lamb model of RSV infection is explained, including all the assays used to evaluate the severity of infection.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Pneumonia II: Pathophysiology

